Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Jacan Angela |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2022

Originalarbeit (Zeitschrift)

** Obermayer, A; Tripolt, NJ; Pferschy, PN; Kojzar, H; Jacan, A; Schauer, M; Aziz, F; Oulhaj, A; Aberer, F; Sourij, C; Obermayer-Pietsch, B; Stadlbauer, V; Sourij, H INTERmittent FASTing in people with insulin-treated type 2 diabetes mellitus - the INTERFAST-2 study protocol.
Diabet Med. 2022; 39(6):e14813 Doi: 10.1111/dme.14813 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Obermayer, A; Tripolt, NJ; Pferschy, PN; Kojzar, H; Aziz, F; Muller, A; Jacan, A; Schauer, M; Jacan, A; Schauer, M; Oulhaj, A; Aberer, F; Sourij, C; Pieber, TR; Obermayer-Pietsch, B; Stadlbauer, V; Sourij, H Intermittent fasting is safe and improves metabolic parameters in people with insulin treated type 2 diabetes: a randomised controlled trial
DIABETOLOGIA. Abstracts 58th Annual Meeting of the EASD. 2022; 65(SUPPL 1):S276-S276.-58th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 19-23, 2022; Stockholm, SWEDEN. [Oral Communication]
Web of Science

 

** Obermayer, A; Tripolt, NJ; Pferschy, PN; Kojzar, H; Aziz, F; Muller, A; Jacan, A; Schauer, M; Oulhaj, A; Aberer, F; Sourij, C; Pieber, TR; Obermayer-Pietsch, B; Stadlbauer, V; Sourij, H Intermittent fasting is safe and improves metabolic parameters in people with insulin-treated type 2 diabetes mellitus a randomized controlled trial
WIEN KLIN WOCHENSCHR. Abstracts der 50. Jahrestagung der Österreichischen Diabetes Gesellschaft. 2022; 134(SUPPL 4):252-253.-50. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 17-19, 2022; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

2020

Originalarbeit (Zeitschrift)

** Jačan, A; Kashofer, K; Zenz, G; Fröhlich, EE; Reichmann, F; Hassan, AM; Holzer, P Synergistic and antagonistic interactions between antibiotics and synbiotics in modifying the murine fecal microbiome.
Eur J Nutr. 2020; 59(5):1831-1844 Doi: 10.1007/s00394-019-02035-z [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Abstract (Zeitschrift)

** Jačan, A; Zenz, G; Fröhlich, EE; Bordag, N; Magnes, C; Kashofer, K; Mayerhofer, R; Reichmann, F; Holzer, P Disruption of colonic microbiome and circulating metabolome in antibiotic-treated mice.
NEUROGASTROENT MOTIL. 2017; 29: 4-4.-Neuro GASTRO 2017; AUG 24-26, 2017; Cork, IRELAND. [Oral Communication]
Web of Science

 

** Zenz, G; Reichmann, F; Jačan, A; Hassan, A; Holzer, P Intermittent fasting does not protect, but exacerbates sickness behavior due to the viral mimic Poly(I:C)
NEUROGASTROENT MOTIL. 2017; 29: 86-86.-Neuro GASTRO 2017; AUG 24-26, 2017; Cork, IRELAND. [Poster]
Web of Science

 

2016

Originalarbeit (Zeitschrift)

** Fröhlich, EE; Farzi, A; Mayerhofer, R; Reichmann, F; Jačan, A; Wagner, B; Zinser, E; Bordag, N; Magnes, C; Fröhlich, E; Kashofer, K; Gorkiewicz, G; Holzer, P Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication.
Brain Behav Immun. 2016; 56(6):140-155 Doi: 10.1016/j.bbi.2016.02.020 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Radnai, B; Sturm, EM; Stančić, A; Jandl, K; Labocha, S; Ferreirós, N; Grill, M; Hasenoehrl, C; Gorkiewicz, G; Marsche, G; Heinemann, Á; Högenauer, C; Schicho, R Eosinophils Contribute to Intestinal Inflammation via Chemoattractant Receptor-homologous Molecule Expressed on Th2 Cells, CRTH2, in Experimental Crohn's Disease.
J Crohns Colitis. 2016; 10(9):1087-1095 Doi: 10.1093/ecco-jcc/jjw061 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Originalarbeit (Zeitschrift)

** Stančić, A; Jandl, K; Hasenöhrl, C; Reichmann, F; Marsche, G; Schuligoi, R; Heinemann, A; Storr, M; Schicho, R The GPR55 antagonist CID16020046 protects against intestinal inflammation.
Neurogastroenterol Motil. 2015; 27(10):1432-1445 Doi: 10.1111/nmo.12639 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2013

Originalarbeit (Zeitschrift)

** Kargl, J; Haybaeck, J; Stančić, A; Andersen, L; Marsche, G; Heinemann, A; Schicho, R O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms.
J Mol Med (Berl). 2013; 91(4):449-458 Doi: 10.1007/s00109-012-0957-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

© Med Uni Graz • Impressum